| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $233,440,522 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21NR020374 | Family partnership and community engagement to support AYA adaptation in serious pediatric illness | 000 | 1 | NIH | 9/5/2023 | $239,384 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21HL172037 | Elucidating the ancestry-specific genetic and environmental architecture of cardiometabolic traits across All of Us ethnic groups | 000 | 1 | NIH | 9/7/2023 | $150,000 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01GM152511 | University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator | 000 | 1 | NIH | 9/21/2023 | $18,000 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 000 | 1 | NIH | 9/1/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UH3CA251139 | Plasma biomarkers for lung cancer diagnosis | 000 | 3 | NIH | 9/6/2023 | $324,669 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30MH135570 | A unique peri-hippocampal mast cell population drives neurodevelopment | 000 | 1 | NIH | 9/1/2023 | $40,219 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI168192 | Mechanisms coordinating the local and systemic resistance to pathogens | 000 | 1 | NIH | 11/2/2022 | $609,077 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01CA275048 | Botswana Smoking Abstinence Reinforcement Trial (BSMART) | 001 | 2 | NIH | 8/17/2023 | $701,239 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD007651 | Multidimensional analytical and computational approach to determine diastereomer compositions in oligonucleotide drug products | 000 | 2 | FDA | 8/2/2023 | $299,555 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33HD103066 | Long-term neurocognitive outcomes of HIV-exposed uninfected children | 000 | 4 | NIH | 6/5/2023 | $617,698 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01EY031731 | Direct Measures of Retinal Blood Flow and Autoregulation as Robust Biomarkers for Early Glaucoma | 000 | 3 | NIH | 7/14/2023 | $326,470 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI155150 | Novel bNAB-based treatment and prevention of HIV-1 | 000 | 3 | NIH | 6/16/2023 | $682,252 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U19AI158930 | Structure, immunity and microbiome: Human 3D biomimetics cervicovaginal models for sexually transmitted infections (SIM-STI) | 000 | 3 | NIH | 3/16/2023 | $1,533,578 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA247647 | Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases | 000 | 3 | NIH | 2/28/2023 | $176,961 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM139854 | The Role of Zinc Fingers in H2S Signaling | 001 | 4 | NIH | 7/26/2023 | $63,218 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01TW011770 | Impact of malaria vector diversity on intervention strategies | 000 | 4 | NIH | 8/2/2023 | $133,731 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08HL153784 | Role of miRNA-TLR7 signaling in platelet activation and dysfunction in sepsis | 000 | 4 | NIH | 5/23/2023 | $155,150 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U54DK126114 | Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC) | 001 | 4 | NIH | 8/21/2023 | $66,211 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U19AI150574 | Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes | 000 | 3 | NIH | 3/20/2023 | $23,254 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UH3HL143192 | Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | 002 | 6 | NIH | 4/28/2023 | $3,349,999 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM136225 | Nucleic Acid Purification System | 001 | 4 | NIH | 4/26/2023 | $44,834 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K24AR076445 | Development of orthopaedic surgeon-scientist expertise in patient-oriented research | 000 | 4 | NIH | 2/10/2023 | $118,479 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI148357 | Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies | 000 | 4 | NIH | 12/6/2022 | $611,307 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | DP1DA048968 | A Multivariate Mediation and Deep Learning Framework for Genome-Connectome -Substance Use Research | 000 | 5 | NIH | 8/9/2023 | $463,500 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AT010333 | Neural correlates of hypoalgesia driven by observation | 000 | 5 | NIH | 7/24/2023 | $703,004 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U19AI142725 | Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens | 001 | 5 | NIH | 2/28/2023 | $1,250,000 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI136756 | Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir | 000 | 5 | NIH | 11/1/2022 | $778,402 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG048069 | Statistical Methods for Kidney Markers as Shared Determinants of Dementia and Physical Disability in Older Adults | 000 | 6 | NIH | 8/14/2023 | $738,981 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI104928 | Functional development of picornavirus-induced membranes throughout infection | 000 | 11 | NIH | 8/8/2023 | $386,250 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL102758 | Daily Regulation of Ionic Currents | 000 | 13 | NIH | 8/24/2023 | $595,239 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK057819 | Intestinal Mucosal Growth in Health and Surgical Diseases | 000 | 20 | NIH | 8/15/2023 | $584,654 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03HL172139 | Leveraging pleiotropy to develop polygenic risk scores for cardiometabolic diseases | 000 | 1 | NIH | 9/7/2023 | $154,500 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM150187 | Biophysical, Structural, and Cellular Dissection of COPI-Dependent Retrograde Trafficking Using a Coronavirus Toolkit | 000 | 1 | NIH | 9/25/2023 | $413,345 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | Assessing intersectional, multilevel and multidimensional structural racism for English- and Spanish-speaking populations in the US | 000 | 1 | NIH | 9/23/2023 | $584,213 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01GM152511 | University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator | 000 | 1 | NIH | 9/21/2023 | $74,971 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U24HD112205 | Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus | 000 | 1 | NIH | 5/19/2023 | $356,709 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21NS133527 | Targeting TREM2 AD/ADRD risk and immunometabolism in human microglia | 000 | 1 | NIH | 8/30/2023 | $424,875 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD106997 | Effects of Attachment-Based Intervention on Low-Income Latino Children's Emerging Health Outcomes: A Randomized Controlled Trial | 001 | 2 | NIH | 8/7/2023 | $536,691 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI174952 | Decoding HIV-1 mediated Hematopathology | 000 | 1 | NIH | 2/6/2023 | $231,750 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI175439 | Anti-flavivirus B cell response analysis to aid vaccine design | 000 | 1 | NIH | 2/6/2023 | $784,842 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03NS128459 | Intravital 2-photon imaging the integration of transplanted embryonic neurons in a mouse model of cerebral ischemia at the subacute phase | 000 | 2 | NIH | 8/24/2023 | $77,250 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL165686 | Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria | 002 | 2 | NIH | 8/8/2023 | $737,139 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG3DA056039 | PTPRD phosphatase inhibitors for stimulant use disorders | 002 | 2 | NIH | 8/2/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG3DA056039 | PTPRD phosphatase inhibitors for stimulant use disorders | 000 | 2 | NIH | 6/9/2023 | $1,391,482 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG3DA056039 | PTPRD phosphatase inhibitors for stimulant use disorders | 001 | 2 | NIH | 6/12/2023 | $386,250 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA259422 | Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation | 000 | 2 | NIH | 8/31/2023 | $176,961 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162120 | Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | 001 | 2 | NIH | 3/6/2023 | $65,372 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30HD107942 | The impact of proliferating mast cells in the developing brain | 000 | 2 | NIH | 3/13/2023 | $45,638 |
| | 2023 | 2023 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167947 | Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4 | 000 | 2 | NIH | 1/6/2023 | $386,250 |
|
